tiprankstipranks
Lantern Pharma, Inc. (LTRN)
NASDAQ:LTRN
US Market

Lantern Pharma (LTRN) Balance Sheet

205 Followers

Lantern Pharma Balance Sheet

Lantern Pharma's total assets for Q4 2023 were $43.65M, a decrease of -8.63% from the previous quarter. LTRN total liabilities were $2.74M for the fiscal quarter, a 16.10% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 43.65M$ 58.84M$ 73.95M$ 20.36M$ 1.43M
Total Liabilities
$ 2.74M$ 2.80M$ 2.38M$ 660.84K$ 489.29K
Total Equity Gross Minority
$ 40.91M$ 56.04M$ 71.57M$ 19.70M$ 943.28K
Total Capitalization
$ 40.97M$ 56.04M$ 71.68M$ 19.81M$ 943.28K
Preferred Stock Equity
----$ 244.00
Capital Lease Obligations
---$ 0.00-
Currency in USD

Lantern Pharma Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis